--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--
US Stock MarketDetailed Quotes
FULC Fulcrum Therapeutics
- 2.970
- -0.020-0.67%
Trading Nov 21 10:08 ET
160.20MMarket Cap-10241P/E (TTM)
3.060High2.955Low61.55KVolume3.020Open2.990Pre Close184.33KTurnover0.19%Turnover RatioLossP/E (Static)53.94MShares13.70052wk High0.62P/B97.42MFloat Cap2.86052wk Low--Dividend TTM32.80MShs Float33.098Historical High--Div YieldTTM3.51%Amplitude2.250Historical Low2.994Avg Price1Lot Size
Fulcrum Therapeutics Key Stats
Fulcrum Therapeutics Q3 2024 Earnings Date
Currency：USDNov 13, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 0 | 0 | 0 |
-100.00% | -100.00% | -- | |
| EPS | -0.40 | -0.35 | +0.05 |
| Beat Est. | -2.56% | +10.26% | +12.48% |
Analyst Rating
Nov 19, 2024
Fulcrum Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Fulcrum Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data